scholarly journals Role of cardiopulmonary exercise testing as a risk-assessment method in patients undergoing intra-abdominal surgery: a systematic review

2016 ◽  
Vol 116 (2) ◽  
pp. 177-191 ◽  
Author(s):  
J. Moran ◽  
F. Wilson ◽  
E. Guinan ◽  
P. McCormick ◽  
J. Hussey ◽  
...  
Keyword(s):  
Systematic Review ◽  
Risk Assessment ◽  
Abdominal Surgery ◽  
Exercise Testing ◽  
Cardiopulmonary Exercise Testing ◽  
Assessment Method ◽  
Cardiopulmonary Exercise ◽  
Risk Assessment Method

The Role of Cardiopulmonary Exercise Testing as a Risk Assessment Tool in Patients Undergoing Oesophagectomy: A Systematic Review and Meta-analysis

2020 ◽  
Vol 27 (10) ◽  
pp. 3783-3796 ◽  
Author(s):  
Jonathan Sivakumar ◽  
Harry Sivakumar ◽  
Matthew Read ◽  
Rhona C. F. Sinclair ◽  
Chistopher P. Snowden ◽  
...  
Keyword(s):  
Systematic Review ◽  
Risk Assessment ◽  
Exercise Testing ◽  
Assessment Tool ◽  
Meta Analysis ◽  
Cardiopulmonary Exercise Testing ◽  
Risk Assessment Tool ◽  
Cardiopulmonary Exercise

scholarly journals Reply to ‘Comment on a Systematic Review of the Role of Cardiopulmonary Exercise Testing in Vascular Surgery’

2012 ◽  
Vol 44 (3) ◽  
pp. 350-351
Author(s):  
E.L. Young ◽  
S. Huddart ◽  
R.P. Pearse ◽  
A. Karthikesalingam ◽  
R.J. Hinchliffe ◽  
...  
Keyword(s):  
Systematic Review ◽  
Vascular Surgery ◽  
Exercise Testing ◽  
Cardiopulmonary Exercise Testing ◽  
Cardiopulmonary Exercise

scholarly journals A Systematic Review of the Role of Cardiopulmonary Exercise Testing in Vascular Surgery

2012 ◽  
Vol 44 (1) ◽  
pp. 64-71 ◽  
Author(s):  
E.L. Young ◽  
A. Karthikesalingam ◽  
S. Huddart ◽  
R.M. Pearse ◽  
R.J. Hinchliffe ◽  
...  
Keyword(s):  
Systematic Review ◽  
Vascular Surgery ◽  
Exercise Testing ◽  
Cardiopulmonary Exercise Testing ◽  
Cardiopulmonary Exercise

Risk stratification in hf with mid-range LVEF: the role of cardiopulmonary exercise testing

2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
B.M.L Rocha ◽  
G.J Lopes Da Cunha ◽  
P.M.D Lopes ◽  
P.N Freitas ◽  
F Gama ◽  
...  
Keyword(s):  
Risk Stratification ◽  
Exercise Testing ◽  
Primary Endpoint ◽  
Prognostic Significance ◽  
Cardiopulmonary Exercise Testing ◽  
Left Ventricular ◽  
Left Ventricular Ejection ◽  
Ventricular Ejection Fraction ◽  
Cardiopulmonary Exercise

Abstract Background Cardiopulmonary exercise testing (CPET) is recommended in the evaluation of selected patients with Heart Failure (HF). Notwithstanding, its prognostic significance has mainly been ascertained in those with left ventricular ejection fraction (LVEF) <40% (i.e., HFrEF). The main goal of our study was to assess the role of CPET in risk stratification of HF with mid-range (40–49%) LVEF (i.e., HFmrEF) compared to HFrEF. Methods We conducted a single-center retrospective study of consecutive patients with HF and LVEF <50% who underwent CPET from 2003–2018. The primary composite endpoint of death, heart transplant or HF hospitalization was assessed. Results Overall, 404 HF patients (mean age 57±11 years, 78.2% male, 55.4% ischemic HF) were included, of whom 321 (79.5%) had HFrEF and 83 (20.5%) HFmrEF. Compared to the former, those with HFmrEF had a significantly higher mean peak oxygen uptake (pVO2) (20.2±6.1 vs 16.1±5.0 mL/kg/min; p<0.001), lower median minute ventilation/carbon dioxide production (VE/VCO2) [35.0 (IQR: 29.1–41.2) vs 39.0 (IQR: 32.0–47.0); p=0.002) and fewer patients with exercise oscillatory ventilation (EOV) (22.0 vs 46.3%; p<0.001). Over a median follow-up of 28.7 (IQR: 13.0–92.3) months, 117 (28.9%) patients died, 53 (13.1%) underwent heart transplantation, and 134 (33.2%) had at least one HF hospitalization. In both HFmrEF and HFrEF, pVO2 <12 mL/kg/min, VE/VCO2 >35 and EOV identified patients at higher risk for events (all p<0.05). In Cox regression multivariate analysis, pVO2 was predictive of the primary endpoint in both HFmrEF and HFrEF (HR per +1 mL/kg/min: 0.81; CI: 0.72–0.92; p=0.001; and HR per +1 mL/kg/min: 0.92; CI: 0.87–0.97; p=0.004), as was EOV (HR: 4.79; CI: 1.41–16.39; p=0.012; and HR: 2.15; CI: 1.51–3.07; p<0.001). VE/VCO2, on the other hand, was predictive of events in HFrEF but not in HFmrEF (HR per unit: 1.03; CI: 1.02–1.05; p<0.001; and HR per unit: 0.99; CI: 0.95–1.03; p=0.512, respectively). ROC curve analysis demonstrated that a pVO2 >16.7 and >15.8 mL/kg/min more accurately identified patients at lower risk for the primary endpoint (NPV: 91.2 and 60.5% for HFmrEF and HFrEF, respectively; both p<0.001). Conclusions CPET is a useful tool in HFmrEF. Both pVO2 and EOV independently predicted the primary endpoint in HFmrEF and HFrEF, contrasting with VE/VCO2, which remained predictive only in latter group. Our findings strengthen the prognostic role of CPET in HF with either reduced or mid-range LVEF. Funding Acknowledgement Type of funding source: None

scholarly journals Pulmonary Capillary Hemangiomatosis: The Role of Invasive Cardiopulmonary Exercise Testing

2015 ◽  
Vol 5 (3) ◽  
pp. 580-586 ◽  
Author(s):  
Hilary M. DuBrock ◽  
Richard L. Kradin ◽  
Josanna M. Rodriguez-Lopez ◽  
Richard N. Channick
Keyword(s):  
Exercise Testing ◽  
Cardiopulmonary Exercise Testing ◽  
Cardiopulmonary Exercise ◽  
Pulmonary Capillary ◽  
Pulmonary Capillary Hemangiomatosis
Sign in / Sign up

Export Citation Format

Share Document